Literature DB >> 31570965

[Pulmonary carcinoids and carcinoids of the small intestine].

K S Winter1, C J Auernhammer2,3, A Todica4,3, J Ricke5,3, C Cyran5,3.   

Abstract

CLINICAL/METHODICAL ISSUE: Pulmonary carcinoids and carcinoids of the small intestine (jejunum and ileum) are often asymptomatic and can affect various parts of the body, which makes diagnosis difficult. STANDARD RADIOLOGICAL
METHODS: Contrast-enhanced computed tomography (CE-CT) is commonly used for primary diagnostics. In case of concomitant pulmonary consolidation (e.g., atelectasis or pneumonia), tumor lesions can be obscured. In addition, differentiation between atypical (AC) and typical carcinoids (TC) is not possible using CT. Small tumors of the small intestine are easily overlooked (sensitivity: 50-85%, specificity: 25-97%, based on the literature). Additional functional imaging evaluation using hybrid imaging techniques can be applied, e.g., positron emission tomography/computed tomography (PET/CT). METHODICAL INNOVATIONS/PERFORMANCE: Depending on the histological characteristics of the tumor, PET/CT scans can be performed with different tracers. Since most carcinoids (e.g., TC) express somatostatin receptors (SSR), 68 gallium-radiolabeled PET tracers (e.g. 68 Ga-DOTA-TOC) are commonly used (sensitivity: 88-93%, specificity: 88-95%, based on the literature). Poorly differentiated carcinoids (e.g., AC) demonstrate lower SSR expression; thus, use of 18F‑FDG (sensitivity: 37-72%, based on the literature) is indicated. In principle, these methods enable a noninvasive prognostic differentiation based on SSR expression and 18F‑FDG uptake. However, the diagnosis must always be histologically confirmed. ACHIEVEMENTS/PRACTICAL RECOMMENDATIONS: Hybrid imaging with CE-CT and PET is useful to detect pulmonary carcinoids and carcinoids of the small intestine, respectively, and can be utilized for primary diagnostics and restaging.

Entities:  

Keywords:  Carcinoid; Computed tomography; Liver metastases; Neuroendocrine tumors; Resection

Mesh:

Substances:

Year:  2019        PMID: 31570965     DOI: 10.1007/s00117-019-00597-x

Source DB:  PubMed          Journal:  Radiologe        ISSN: 0033-832X            Impact factor:   0.635


  28 in total

Review 1.  Carcinoid tumors.

Authors:  M H Kulke; R J Mayer
Journal:  N Engl J Med       Date:  1999-03-18       Impact factor: 91.245

Review 2.  Carcinoid tumors.

Authors:  Rebecca S Sippel; Herbert Chen
Journal:  Surg Oncol Clin N Am       Date:  2006-07       Impact factor: 3.495

Review 3.  Pulmonary neuroendocrine (carcinoid) tumors: European Neuroendocrine Tumor Society expert consensus and recommendations for best practice for typical and atypical pulmonary carcinoids.

Authors:  M E Caplin; E Baudin; P Ferolla; P Filosso; M Garcia-Yuste; E Lim; K Oberg; G Pelosi; A Perren; R E Rossi; W D Travis
Journal:  Ann Oncol       Date:  2015-02-02       Impact factor: 32.976

Review 4.  Functional imaging evaluation in the detection, diagnosis, and histologic differentiation of pulmonary neuroendocrine tumors.

Authors:  Filippo Lococo; Giorgio Treglia; Alfredo Cesario; Massimiliano Paci; Angelina Filice; Annibale Versari; Pier Luigi Filosso
Journal:  Thorac Surg Clin       Date:  2014-06-06       Impact factor: 1.750

5.  The role of 68Ga-DOTATATE PET in patients with neuroendocrine tumors and negative or equivocal findings on 111In-DTPA-octreotide scintigraphy.

Authors:  Rajaventhan Srirajaskanthan; Irfan Kayani; Anne Marie Quigley; Jade Soh; Martyn E Caplin; Jamshed Bomanji
Journal:  J Nucl Med       Date:  2010-05-19       Impact factor: 10.057

Review 6.  Carcinoid tumour.

Authors:  M E Caplin; J R Buscombe; A J Hilson; A L Jones; A F Watkinson; A K Burroughs
Journal:  Lancet       Date:  1998-09-05       Impact factor: 79.321

7.  Laparoscopic surgical exploration is an effective strategy for locating occult primary neuroendocrine tumors.

Authors:  Kristen P Massimino; Esther Han; SuEllen J Pommier; Rodney F Pommier
Journal:  Am J Surg       Date:  2012-03-27       Impact factor: 2.565

Review 8.  [Pulmonary neuroendocrine tumors in the new WHO 2015 classification: Start of breaking new grounds?].

Authors:  P A Schnabel; K Junker
Journal:  Pathologe       Date:  2015-05       Impact factor: 1.011

9.  Prospective evaluation and treatment of familial carcinoid small intestine neuroendocrine tumors (SI-NETs).

Authors:  Marybeth S Hughes; Saïd C Azoury; Yasmine Assadipour; David M Straughan; Apurva N Trivedi; Ramona M Lim; Grishma Joy; Mark T Voellinger; Derek M Tang; Aradhana M Venkatesan; Clara C Chen; Adeline Louie; Martha M Quezado; Joanne Forbes; Stephen A Wank
Journal:  Surgery       Date:  2015-10-09       Impact factor: 3.982

10.  The utility of 18F-FDG and 68Ga-DOTA-Peptide PET/CT in the evaluation of primary pulmonary carcinoid: A systematic review and meta-analysis.

Authors:  Yuanyuan Jiang; Guozhu Hou; Wuying Cheng
Journal:  Medicine (Baltimore)       Date:  2019-03       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.